Editor(s):
(1) Dr. John Yahya I. Elshimali, Professor, UCLA School of Medicine, Charles R. Drew University of Medicine and Science, California, USA.
(2) Dr. Alaa Eldin A. Hamza, Professor, National Organization for Drug Control and Research (NODCAR), Egypt.
(3) Dr. S. M. Chitra, Lecturer, Government Siddha Medical College, India.
Reviewers:
(1) Areeg Kamel Mahdi, University of Baghdad, Iraq.
(2) M. Pavani, Avanthi Institute of Pharmaceutical Sciences, India.
(3) Amit Gupta, I B S, Dr. B R Ambedkar University, India.
(4) Sharad Vats, Banasthali Vidyapith, India.
Additional Reviewers:
(1) Sk Chand Basha, KL (Deemed to be University), India.
(2) Bahareh Allahverdi Mamaghani, Research Institute of Forest and Rangelands, Iran.
(3) Enas Abdulsahib Badi, Iraq.
(4) Lydia Bonareri Nyamwamu, Moi University, Kenya.
(5) Maria Ynelda Martinez Aquino, Venezuela.
(6) N.Anitha, Sultan-Ul-Uloom College of Pharmacy, India.
(7) Niculae Mihaela, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, Romania.
(8) Samah Metwally Mahmoud Abd EL-Aziz, The National Research Centre, Egypt.
(9) S. Vaidehi, India.
(10) Vasukidevi Ramachandran, Bharath Institute of Higher Education and Research, India.
Additional Reviewers: (Comments received after deadline)
(1) Miricescu Daniela, Romania.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.77/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Areeg Kamel Mahdi, Iraq) | File 1 | File 2
Stage 2 | Peer review report_2 (M. Pavani, India) | File 1 | File 2
Stage 2 | Peer review report_3 (Amit Gupta, India) | File 1 | NA
Stage 2 | Peer review report_4 (Sharad Vats, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | NA
Stage 3 | Revised_MS_v2_and_Feedback_v2 | File 1 | File 2